How to earn $500 a month from this stock?

07:32am, Wednesday, 29'th Nov 2023
Pfizer's (NASDAQ: PFE) stock continued its 11-month decline in November after its third-quarter sales missed expectations amid waning demand for Covid products.
Arecor Therapeutics PLC (AIM:AREC) announces an expanded collaboration with Eli Lilly and Company that will see the former's Arestat technology use to develop a new enhanced liquid formulation of an
Eli Lilly and Company (NYSE:LLY ) 6th Evercore ISI HealthCONx Conference November 28, 2023 3:50 PM ET Company Participants Dan Skovronsky - EVP, Chief Scientific and Medical Officer Conference Call Pa
Eli Lilly (LLY), Novo Nordisk (NVO) and Novartis (NVS) have outperformed the industry this year.
Overweight or obese adults lost more weight and shed pounds faster using Eli Lilly's Mounjaro than those taking Novo Nordisk's popular rival weight loss drug, according to an analysis of health record
Dr. Nick Stucky, VP of Research at Truveta, joins 'Fast Money' to talk the results of a study comparing weight-loss drugs Mounjaro and Ozempic.
Eli Lilly and Co (NYSE:LLY)'s diabetes drug Mounjaro is more effective for weight loss than Novo Nordisk (NYSE:NVO)'s Ozempic in overweight or obese adults, a real-world analysis by Truveta Research r
Mounjaro – a popular treatment for diabetes is more effective for losing weight than Ozempic, as per a large study of real-word data by Truveta Research.
For years now, a significant cohort of investors gravitated towards the allure of the S&P 500 index over individual stocks.

3 Top Stocks That'll Make Smart Investors Rich

05:00am, Monday, 27'th Nov 2023
Investors should select a variety of companies with strong earnings prospects and hold on for a number of years. It's a great idea to include companies with a track record of success and leadership in
AbbVie is a Dividend King with a bright future. Eli Lilly's dividend is just icing on the cake, with the company's growth prospects taking center stage.
Emily Field, Barclays, joins 'Squawk Box' to discuss the latest news in the weight-loss drug market, the news to watch out for next year, and how investors should play the weight-loss drug market.
Lilly (LLY) is making rapid pipeline progress in areas like obesity, diabetes and Alzheimer's. Mounjaro and Zepbound are expected to be key top-line drivers for Lilly.

Will Eli Lilly Be Worth More Than Tesla by 2027?

09:05am, Thursday, 23'rd Nov 2023
Eli Lilly's shares climbed rapidly in recent years. The pharma giant's track record of bringing highly successful drugs into the market means there's a long growth runway.
The U.S. continues to spend more money on healthcare than any other country. Healthcare spending totaled $4.3 trillion, according to the American Medical Association.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE